Senores Pharmaceuticals Limited IPO (Senores Pharmaceuticals Limited IPO) Details

Incorporated: December 2017
Industry: Pharmaceuticals
Core Focus: Development and manufacturing of pharmaceutical products for regulated and emerging markets.

---

Key Business Highlights

1. Product Portfolio:

   • Offers a diverse range of 55 pharmaceutical products as of September 30, 2024.
   • Focus on key therapeutic areas such as antibiotics, anti-fungal treatments, critical care injectables, and APIs.
   • Notable products include:
     • Amphetamine Sulfate Tablets
     • Hydroxychloroquine Sulfate Tablets
     • Methadone Hydrochloride Tablets
     • Morphine Sulfate Tablets
     • Cyclobenzaprine Hydrochloride Tablets
     • Ivermectin Tablets

2. Target Markets:

   • Regulated markets: United States, Canada, and the United Kingdom.
   • Emerging markets: Operations in 43 countries, supported by partnerships with distributors and hospitals.

3. Manufacturing and R&D:

   • Manufacturing Facility: Ahmedabad, Gujarat, approved by the US FDA.
   • R&D Facilities:
     • Three dedicated units located in India and the US, driving innovation and the development of complex products.

---

Competitive Strengths

1. Regulated Market Expertise:

   • Offers a unique, tailored portfolio of generic pharmaceutical products with long-term marketing agreements in the US, Canada, and UK markets.

2. Emerging Market Presence:

   • Significant foothold in 43 countries with a product lineup that includes speciality and complex pharmaceuticals.

3. Strong Manufacturing Capability:

   • US FDA-approved manufacturing facility ensures high-quality production standards and compliance with global regulations.

4. Robust R&D Capabilities:

   • A strong focus on developing differentiated and complex pharmaceutical products to stay ahead in a competitive landscape.

5. Experienced Management Team:

   • A professional team driving strategic growth and ensuring quality, innovation, and market adaptability.

---

Strategic Focus

• Innovation:

  • Emphasis on creating underpenetrated and complex pharmaceuticals to address global healthcare needs.

• Affordable Healthcare:

  • Committed to making healthcare more accessible and cost-effective, leveraging economies of scale and efficient manufacturing practices.

• Dynamic Market Strategy:

  • A strategic approach to market entry and expansion in both regulated and emerging markets.

---

Key Achievements

• Successfully launched 55 products in regulated and emerging markets within a short time frame.
• Built long-term partnerships with distributors and hospitals in India and abroad.
• Established a global presence with a focus on high-demand markets.
• Recognized for its reliability and quality by customers worldwide.

---

Conclusion

Senores Pharmaceuticals Limited has quickly positioned itself as a key player in the generic pharmaceutical industry, with a stronghold in regulated markets and a growing presence in emerging regions. Its commitment to innovation, quality manufacturing, and accessible healthcare solutions underscores its vision for global growth and industry leadership.